JP2014505065A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505065A5
JP2014505065A5 JP2013550895A JP2013550895A JP2014505065A5 JP 2014505065 A5 JP2014505065 A5 JP 2014505065A5 JP 2013550895 A JP2013550895 A JP 2013550895A JP 2013550895 A JP2013550895 A JP 2013550895A JP 2014505065 A5 JP2014505065 A5 JP 2014505065A5
Authority
JP
Japan
Prior art keywords
probiotic
use according
per
intended
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013550895A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014505065A (ja
JP5956467B2 (ja
Filing date
Publication date
Priority claimed from EP11000744.0A external-priority patent/EP2481299B1/en
Application filed filed Critical
Publication of JP2014505065A publication Critical patent/JP2014505065A/ja
Publication of JP2014505065A5 publication Critical patent/JP2014505065A5/ja
Application granted granted Critical
Publication of JP5956467B2 publication Critical patent/JP5956467B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013550895A 2011-01-31 2012-01-27 消化器疾患への適用のためのビフィドバクテリウム・ビフィドゥムの菌株 Active JP5956467B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11000744.0 2011-01-31
EP11000744.0A EP2481299B1 (en) 2011-01-31 2011-01-31 Bifidobacterium bifidum strains for application in gastrointestinal diseases
PCT/EP2012/051369 WO2012104226A1 (en) 2011-01-31 2012-01-27 Bifidobacterium bifidum strains for application in gastrointestinal diseases

Publications (3)

Publication Number Publication Date
JP2014505065A JP2014505065A (ja) 2014-02-27
JP2014505065A5 true JP2014505065A5 (enExample) 2015-02-26
JP5956467B2 JP5956467B2 (ja) 2016-07-27

Family

ID=43901563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013550895A Active JP5956467B2 (ja) 2011-01-31 2012-01-27 消化器疾患への適用のためのビフィドバクテリウム・ビフィドゥムの菌株

Country Status (15)

Country Link
US (1) US9408879B2 (enExample)
EP (1) EP2481299B1 (enExample)
JP (1) JP5956467B2 (enExample)
CN (1) CN103476273A (enExample)
AU (1) AU2012213576B2 (enExample)
BR (1) BR112013019258B1 (enExample)
CA (1) CA2825980C (enExample)
DK (1) DK2481299T3 (enExample)
ES (1) ES2610908T3 (enExample)
HR (1) HRP20161792T1 (enExample)
HU (1) HUE033189T2 (enExample)
PL (1) PL2481299T3 (enExample)
PT (1) PT2481299T (enExample)
RU (1) RU2603285C2 (enExample)
WO (1) WO2012104226A1 (enExample)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN103266076B (zh) * 2013-06-04 2014-10-29 神舟太空产品高科技成果推广中心集团有限公司 太空诱变高效两歧双歧杆菌、其应用及其胶囊制剂的制备方法
CN104546945A (zh) * 2014-09-30 2015-04-29 深圳华大基因科技有限公司 两歧双歧杆菌在治疗或预防类风湿性关节炎或其相关疾病中的用途
EP3065748B1 (en) 2014-12-23 2017-11-22 4D Pharma Research Limited A bacteroides thetaiotaomicron strain and its use in reducing inflammation
SMT201800291T1 (it) 2014-12-23 2018-07-17 4D Pharma Res Limited Polipeptide pirina e modulazione immunitaria
EP3268017A1 (en) * 2015-03-09 2018-01-17 Bioimmunizer SAGL Anti-age composition comprising a combination of antioxidant agents in association with bifidobacteria and cell walls isolated from probiotics
SG10201912319SA (en) 2015-06-15 2020-02-27 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PT3307288T (pt) 2015-06-15 2019-10-17 4D Pharma Res Ltd Composições compreendendo estirpes bacterianas
CN108271354B (zh) 2015-06-15 2022-07-29 4D制药研究有限公司 包含细菌菌株的组合物
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
JP6637725B2 (ja) * 2015-10-28 2020-01-29 ビオフェルミン製薬株式会社 ウイルス感染症の予防及び/又は治療剤
GB2561748B (en) 2015-11-20 2019-05-08 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
MD3313423T2 (ro) 2016-03-04 2019-10-31 4D Pharma Plc Compoziții care conțin tulpini bacteriene de Blautia pentru tratamentul hipersensibilității viscerale
EP3442549B1 (en) * 2016-04-14 2024-03-20 International N&H Denmark ApS Bifidobacteria for increasing lean body mass
TWI802545B (zh) 2016-07-13 2023-05-21 英商4D製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
CN106579414A (zh) * 2016-12-26 2017-04-26 北京康比特体育科技股份有限公司 一种缓解运动性腹泻的组合物
CN106834187B (zh) * 2017-03-06 2020-08-25 江南大学 一种两歧双歧杆菌及其用途
WO2018165563A1 (en) * 2017-03-09 2018-09-13 The Clorox Company Probiotic capsule and methods of preparing the same
JP2018177703A (ja) * 2017-04-14 2018-11-15 株式会社明治 Toll様受容体2活性化用組成物
CN110913878A (zh) 2017-05-22 2020-03-24 4D制药研究有限公司 包含细菌菌株的组合物
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
HRP20202033T1 (hr) 2017-06-14 2021-02-19 4D Pharma Research Limited Sastavi koji sadrže bakterijske sojeve
TW201919668A (zh) 2017-06-14 2019-06-01 英商4D製藥研究有限公司 包含細菌品系之組成物
HUE053488T2 (hu) 2017-06-14 2021-06-28 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
KR102760825B1 (ko) * 2018-01-29 2025-02-03 프리시젼바이오틱스 그룹 리미티드 과민성 대장 증후군의 예방 및 치료를 위한 조합 생성물
KR102023700B1 (ko) * 2018-01-31 2019-09-20 주식회사 비피도 비피도박테리움을 함유한 류마티스관절염 개선용, 치료용 또는 예방용 조성물
CA3100821A1 (en) * 2018-06-22 2019-12-26 Synformulas Gmbh Non-viable bifidobacterium bifidum bacteria and uses thereof
BR112021007249A2 (pt) * 2019-01-16 2021-08-10 N.V. Nutricia composições nutricionais
IT201900011193A1 (it) * 2019-07-08 2021-01-08 Sofar Spa Ceppo di batteri Bifidobacterium bifidum, sue composizioni e relativi usi
BR112022004032A2 (pt) * 2019-09-05 2022-05-24 Superbrewed Food Inc Composições probióticas mixotróficas e usos das mesmas no tratamento de distensão abdominal
IT201900016811A1 (it) * 2019-09-20 2021-03-20 Sofar Spa Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali
CN112870232A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99提升肠道细菌感染抗性和肠道免疫力的应用
CN111110704B (zh) * 2020-02-14 2023-03-28 上海城建职业学院 一种益生菌菌剂、滴剂及其制备方法和应用
CN111743998A (zh) * 2020-06-04 2020-10-09 中通美雅生命健康(深圳)有限公司 用于辅助治疗肠炎组合物及其制备方法
RU2735717C1 (ru) * 2020-06-15 2020-11-06 Общество с ограниченной ответственностью "АВАН" Штамм Bifidobacterium bifidum, используемый в качестве пробиотика
CA3193257A1 (en) * 2020-09-23 2022-03-31 Dong Hyun Kim Novel lactic acid bacteria and use thereof
CN113943682B (zh) * 2020-11-12 2023-07-04 江南大学 缓解便秘的长双歧杆菌长亚种及其制备的发酵食品与益生菌制剂
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
EP4243602A4 (en) 2020-11-16 2024-11-13 Orcosa Inc. Improved use of cannabinoids in the treatment of alzheimer's disease
CN112980734B (zh) * 2021-03-24 2022-07-22 江南大学 一株缓解便秘并调节肠道菌群紊乱的两歧双歧杆菌及其应用
CN113025526B (zh) * 2021-03-24 2022-09-27 江南大学 一株减少结肠病理损伤且具有缓解便秘作用的两歧双歧杆菌
CN113234619B (zh) * 2021-04-10 2022-07-05 江南大学 一株两歧双歧杆菌及其在缓解肠道损伤中的应用
CN116004416B (zh) * 2022-07-13 2024-05-10 四川大学 婴幼儿肠道来源的两歧双歧杆菌的应用
CN116286439A (zh) * 2022-07-13 2023-06-23 四川大学 一株婴幼儿肠道来源的两歧双歧杆菌及应用
CN115838662A (zh) * 2022-11-02 2023-03-24 江南大学 一株具有缓解克罗恩病潜力的两歧双歧杆菌
EP4631511A1 (en) * 2023-03-21 2025-10-15 Sichuan Anaerobic Biotechnology Co., Ltd. Probiotic and use thereof
CN118044616A (zh) * 2023-09-05 2024-05-17 厦门大学 一种合生元及其用途
WO2025059424A1 (en) * 2023-09-15 2025-03-20 Biohm Health Inc. Pro-biotic compositions and methods for treatment of stress
CN118879582B (zh) * 2024-09-19 2025-03-25 微康益生菌(苏州)股份有限公司 一种细胞完整、分散均匀、稳定性强的后生元制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29150A (id) 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
RU2152993C1 (ru) * 1999-11-30 2000-07-20 Государственный научный центр РФ Институт медико-биологических проблем Штамм bifidobacterium bifidum вкпм ас-1578, используемый для приготовления бактериальных препаратов и продуктов питания
RU2184146C1 (ru) * 2001-01-29 2002-06-27 Закрытое акционерное общество "Партнер" Штамм bifidobacterium bifidum 45 вкпм ас-1621, используемый для приготовления бактериальных препаратов и продуктов питания
ES2284028T5 (es) * 2003-06-30 2014-12-04 Clasado Inc. Nueva composición de galactooligosacárido y la preparación de la misma
PL1673100T3 (pl) * 2004-08-05 2008-01-31 Anidral Srl Szczepy bakterii Bifidobacterium wytwarzające kwas foliowy, preparaty i ich zastosowanie
EP1885383B1 (en) * 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
CN100490826C (zh) * 2005-07-05 2009-05-27 广州市微生物研究所 多联活性双歧杆菌产品的制备方法
CN101228262B (zh) * 2005-07-21 2011-04-20 株式会社益力多本社 新型双歧杆菌属细菌及其利用
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
MX2009010187A (es) * 2007-03-27 2009-10-19 Procter & Gamble Metodos y estuches para administracion de probioticos.
EP2270133B1 (en) * 2008-04-22 2015-06-24 Corporación Alimentaria Peñasanta (Capsa) Method for obtaining a novel strain of bifidobacterium bifidum with activity against infection by helicobacter pylori
CA2721981A1 (en) * 2008-05-01 2009-11-05 The Procter & Gamble Company Methods and kits for the treatment of inflammatory bowel disorder conditions
ES2558960T3 (es) * 2008-06-13 2016-02-09 N.V. Nutricia Composición nutricional para la prevención de infecciones

Similar Documents

Publication Publication Date Title
JP2014505065A5 (enExample)
HRP20161792T1 (hr) Sojevi bifidobacterium bifiduma za primjenu u gastrointestinalnim bolestima
Ojetti et al. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial
Sood et al. The probiotic preparation, VSL# 3 induces remission in patients with mild-to-moderately active ulcerative colitis
ES2610994T3 (es) Bifidobacterium animalis subsp. lactis para el uso en la reducción del dolor abdominal en una mujer postmenopáusica
JP2018536427A5 (enExample)
JP2019508486A5 (enExample)
RU2018119287A (ru) Бифидобактерии лонгум для лечения ожирения и связанных с ним метаболических нарушений
RU2017118358A (ru) Применение l. reuteri для восстановления после дисбиоза микробиоты на ранних этапах развития
ES2763350B2 (es) Cepa de christensenella minuta y uso de la misma
RU2009139657A (ru) Снижение риска диареи
JP2013522315A5 (enExample)
RU2017122615A (ru) Применение пробиотиков для усиления мужской фертильности
Onyenweaku et al. Research Article Health Benefits of Probiotics
Hijova et al. Effects of probiotics and prebiotics in ulcerative colitis
Merenstein et al. Probiotics and prebiotics
TW201427603A (zh) 過敏症改善劑
WO2018078599A4 (en) Composition for the preventive or curative treatment of liver disorders
Kruis Probiotics
Yoon et al. Studies on the biological activity of synbiotics: A review
TW201818828A (zh) 抑制腸道內乳桿菌屬乳酸菌減少用之組成物
Kim The effects of probiotics on the treatment of Helicobacter pylori eradication
Khatri et al. Gut Homeostasis; Microbial Cross Talks In Health and Disease Management.
JP6830620B2 (ja) 非ステロイド系鎮痛薬起因性小腸傷害予防及び/又は改善剤
Desai et al. A revitalising approach towards aging: Unveiling the potential use of probiotics for wellness in elderly populations